What medical and pharmaceutical/bioscience/medical device meeting planners and continuing medical education professionals need to know to plan meetings and CME activities for healthcare professionals.
While it’s great that CME providers have put work into measurement and reporting, it’s now time to focus on performance improvement that leads to higher-quality healthcare.
After a recent #CMEReg Twitter chat about how the Sunshine Act could potentially affect CME, Derek Warnick and the CME Coalition's Chris Lamond put together a survey for docs to find out how having what commercial support from pharma companies was...
There are a couple of posts on Seth Godin's blog that really rang my CME bell, so I thought I'd share them with you. The first is called How'd It Work Out?, and is about how we seldom check in long after the fact to see the long-term results of...
As you may have heard, CMS proposed a rule related to the Physician Payment Sunshine Act that would make CME providers responsible for reporting monies from pharma that are indirectly spent on physicians—i.e., for things like honoraria and other...
Experts from the Accreditation Council for CME, the Food and Drug Administration, and the commercial support community address how to ensure REMS activities align with the ACCME’s Standards for Commercial Support.
Chris Lamond and Andy Rosenberg from the CME Coalition joined a discussion on a special #CMEReg chat on February 12 to talk about a proposed amendment to the Sunshine Act that has been causing anxiety in most CME providers who learn about it...
There’s no better way to get inside a market niche than to meet its players face to face at a conference targeted to that one subject and that one audience. Medical Meetings magazine, with co-organizer CBI, is hosting the 8th Annual Pharmaceutical...
